Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia.

Archive ouverte

Korchia, Théo | Tastevin, Maud | Sunhary de Verville, Pierre-Louis | Joober, Ridha | Andrieu-Haller, Christelle | Faugere, Mélanie | O, Godin | D, Etchecopar-Etchart | Berna, Fabrice | Aouizerate, Bruno | Capdevielle, Delphine | Chereau, Isabelle | Clauss-Kobayashi, Julie | Coulon, Nathalie | Dorey, Jean-Michel | Dubertret, Caroline | Dubreucq, Julien | Mallet, Jasmina | Misdrahi, David | Passerieux, Christine | Rey, Romain | Schürhoff, Franck | Szoke, Andrei | Urbach, Mathieu | Leboyer, Marion | Llorca, Pierre-Michel | Lançon, Christophe | Richieri, Raphaelle | Boyer, Laurent | Fond, Guillaume

Edité par CCSD ; Taylor & Francis -

International audience. Background: In people with schizophrenia, major areas of everyday life are impaired, including independent living, productive activities, social relationships and overall quality of life. Enhanced understanding of factors that hinder real-life functioning is vital for treatments to translate into more positive outcomes.Aim: The goal of the present study was to identify factors associated with motivation deficits in real-life schizophrenia, and to assess its contribution to impaired functioning and quality of life.Methods: Based on previous literature and clinical experience, several factors were selected and grouped into factors potentially explaining motivation deficits. Some of these variables were never investigated before in relationship with motivation deficits.Results: In 561 patients with schizophrenia of the national FACE-SZ cohort living in the community, 235(41.9%) reported severe motivation deficits. These deficits were found to be significantly associated with impaired socially useful activities, psychological and physical quality of life (in almost all domains), alcohol use disorder (aOR =2.141, p = 0.021), severe nicotine dependence (aOR =2.906, p < 0.001) independently of age and sex. No significant association was found for body mass index, metabolic syndrome or physical activity level. In the second model, we identified the following modifiable factors associated with motivation deficits: history of suicide attempt (aOR =2.297, p = 0.001), positive symptoms (aOR =1.052, p = 0.006), current major depressive episode (aOR =2.627, p < 0.001), sleep disorders (aOR =1.474, p = 0.024) and lower medication adherence (aOR =0.836, p = 0.001) independently of gender, current alcohol use disorder, second-generation antipsychotics and akathisia. No significant association was found for negative symptoms, childhood trauma and inflammation. These results were maintained after removing patients with schizoaffective disorders or those with major depressive disorder.Interpretation: Motivation deficits are frequent and remain persistent unmet need in real-world schizophrenia that should be addressed in future guidelines. Based on our results, literature and clinical experience, we recommend to address in priority major depression, sleep, suicide, positive symptoms (when present and as early as possible) and medication adherence to improve motivation deficits of schizophrenia.

Consulter en ligne

Suggestions

Du même auteur

Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)

Archive ouverte | Sunhary de Verville, Pierre-Louis | CCSD

International audience. The World Health Organization (WHO) recommends adults complete 150-300 min per week of moderate physical activity or 75-150 min of vigorous physical activity or an equivalent combination of b...

Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study

Archive ouverte | Dubreucq, Julien | CCSD

International audience. Recovery is a multidimensional construct that can be defined either from a clinical perspective or from a consumer-focused one, as a self-broadening process aimed at living a meaningful life ...

Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort

Archive ouverte | Fond, Guillaume | CCSD

International audience. Background: Peripheral inflammation is associated with impaired prognosis in schizophrenia (SZ). Highly sensitive C-reactive protein (hs-CRP) is the most used inflammatory biomarker in daily ...

Chargement des enrichissements...